ALS patients with an intermediate CAA/G expansion in ATXN2 present with the pathological hallmark of cytoplasmic TDP-43 aggregates in affected neurons (40,44), indicating that mutation in ATXN2 impacts ALS disease features. Here, ATXN2 is linked to amyotrophic lateral sclerosis.